Reversible delirium in an advanced cancer patient.
Delirium is still one of the most common and distressing symptoms in palliative care patients. Causes and pathophysiology of this neuropsychiatric dysfunction are multifactorial. Recent studies indicate that the interaction of special triggers facilitates development of delirium. Some of them are reversible. This case report presents a reversible delirium in an advanced cancer patient and offers a list of possible delirogen medications. This list might be useful to prevent delirium, particularly in older people.
Unit of Palliative Care, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria. katharina.kierner@meduniwien.ac.at
Katharina A
KA
Kierner
Christian
C
Jagsch
Herbert H
HH
Watzke
D000588:Amines / Q000008:administration & dosage / Q000009:adverse effects; D000700:Analgesics / Q000008:administration & dosage / Q000009:adverse effects; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects; D001859:Bone Neoplasms / Q000473:pathology / Q000523:psychology* / Q000556:secondary* / Q000628:therapy; D001943:Breast Neoplasms / Q000473:pathology / Q000523:psychology* / Q000628:therapy; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000473:pathology / Q000523:psychology* / Q000556:secondary* / Q000628:therapy; D018275:Carcinoma, Lobular / Q000473:pathology / Q000523:psychology* / Q000556:secondary*; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000009:adverse effects; D003693:Delirium / Q000139:chemically induced / Q000188:drug therapy / Q000523:psychology*; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D000077206:Gabapentin; D006801:Humans; D008140:Lorazepam / Q000008:administration & dosage; D008874:Midazolam / Q000008:administration & dosage; D008875:Middle Aged; D009367:Neoplasm Staging; D009378:Neoplasms, Multiple Primary / Q000473:pathology / Q000523:psychology* / Q000628:therapy; D010166:Palliative Care / Q000379:methods* / Q000523:psychology*; D013125:Spinal Neoplasms / Q000473:pathology / Q000523:psychology / Q000556:secondary / Q000628:therapy; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000009:adverse effects
D000588:Amines; D000700:Analgesics; D000701:Analgesics, Opioid; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D008140:Lorazepam; D008874:Midazolam